Sale!

LOXL1 Gene Exfoliation syndrome susceptibility to Genetic Test

4,400 د.إ

-21%

The LOXL1 Gene Exfoliation Syndrome Susceptibility Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify genetic predispositions to exfoliation syndrome (XFS), a significant risk factor for glaucoma. This condition is characterized by the accumulation of extracellular fibrillar material in the eye, leading to increased intraocular pressure and potential vision loss. The LOXL1 gene has been identified as a critical factor in the development of XFS, making this test a crucial tool for early detection and management of the syndrome.

The test involves analyzing the patient’s DNA to detect mutations in the LOXL1 gene that are associated with an increased risk of developing exfoliation syndrome. Early identification of these genetic markers can enable proactive monitoring and intervention, potentially preserving vision by preventing the progression to glaucoma.

Priced at 4400 AED, the LOXL1 Gene Exfoliation Syndrome Susceptibility Genetic Test is accessible at DNA Labs UAE, where cutting-edge technology and expertise ensure accurate and reliable results. Individuals with a family history of glaucoma or exfoliation syndrome, or those exhibiting early symptoms, may particularly benefit from this test, enabling them to take timely steps towards eye health management.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

LOXL1 Gene Exfoliation Syndrome Susceptibility to Genetic Test

Genetic testing plays a crucial role in identifying individuals who may be at risk for certain health conditions. One such condition is exfoliation syndrome, which affects the eyes. DNA Labs UAE offers a comprehensive LOXL1 Gene Exfoliation Syndrome Susceptibility to Genetic Test at a cost of 4400.0 AED.

Test Components and Details

  • Test Name: LOXL1 Gene Exfoliation Syndrome Susceptibility to Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ophthalmology Disorders
  • Doctor: Ophthalmologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the LOXL1 Gene Exfoliation Syndrome Susceptibility to Genetic Test, it is important to provide the clinical history of the patient. A genetic counseling session may be conducted to draw a pedigree chart of family members affected by LOXL1 Gene Exfoliation Syndrome Susceptibility to NGS Genetic DNA Test gene LOXL1.

About Exfoliation Syndrome and NGS Genetic Testing

Exfoliation syndrome is a condition characterized by the buildup of protein material in the eye, leading to clogging of the drainage system and increased eye pressure. This can eventually result in glaucoma. The LOXL1 gene is associated with exfoliation syndrome.

NGS (Next Generation Sequencing) genetic testing is a cutting-edge technology that analyzes DNA to identify variations or mutations in genes associated with certain health conditions, including exfoliation syndrome. By detecting LOXL1 gene variants, this test helps identify individuals who may be at increased risk for developing exfoliation syndrome.

Benefits of Genetic Testing

A genetic test for LOXL1 gene variants can be beneficial for individuals with a family history of exfoliation syndrome or those experiencing symptoms such as blurred vision, eye pain, or increased eye pressure. While having a variant in the LOXL1 gene does not guarantee the development of exfoliation syndrome, genetic testing provides valuable information for individuals and healthcare providers in managing eye health and reducing the risk of complications associated with this condition.

For accurate and reliable LOXL1 Gene Exfoliation Syndrome Susceptibility to Genetic Testing, trust DNA Labs UAE. Our advanced NGS Technology and expertise in genetics ensure accurate results and timely report delivery. Contact our Genetics Test Department today to schedule an appointment with our Ophthalmologist and take control of your eye health.

Test Name LOXL1 Gene Exfoliation syndrome susceptibility to Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ophthalmology Disorders
Doctor Ophthalmologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for LOXL1 Gene Exfoliation syndrome, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with LOXL1 Gene Exfoliation syndrome, susceptibility to NGS Genetic DNA Test gene LOXL1
Test Details

The LOXL1 gene is associated with exfoliation syndrome, which is a condition that affects the eyes. Exfoliation syndrome is characterized by the buildup of a protein material in the eye that can cause clogging of the drainage system, leading to increased pressure in the eye and eventually, glaucoma.

NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze DNA. This type of testing can identify variations or mutations in genes that may be associated with certain health conditions, including exfoliation syndrome.

A genetic test for LOXL1 gene variants associated with exfoliation syndrome can help identify individuals who may be at increased risk for developing this condition. This information can be useful for individuals who have a family history of exfoliation syndrome or for those who are experiencing symptoms such as blurred vision, eye pain, or increased pressure in the eye.

It is important to note that having a variant in the LOXL1 gene does not necessarily mean that an individual will develop exfoliation syndrome, as other genetic and environmental factors may also play a role in the development of this condition. However, genetic testing can provide valuable information for individuals and their healthcare providers in managing their eye health and reducing their risk of developing complications associated with exfoliation syndrome.